Public Sector Pension Investment Board (PSP Investments)’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-118,708
Closed -$507K 1331
2023
Q2
$507K Buy
118,708
+5,180
+5% +$30.6K ﹤0.01% 1352
2023
Q1
$777K Sell
113,528
-5,422
-5% -$42.1K 0.01% 1285
2022
Q4
$942K Hold
118,950
0.01% 1240
2022
Q3
$1.14M Hold
118,950
0.01% 1101
2022
Q2
$861K Hold
118,950
0.01% 1213
2022
Q1
$1.54M Sell
118,950
-10,860
-8% -$138K 0.01% 1129
2021
Q4
$2.07M Buy
129,810
+1,540
+1% +$26.9K 0.01% 1067
2021
Q3
$2.06M Sell
128,270
-7,950
-6% -$117K 0.01% 1081
2021
Q2
$1.88M Sell
136,220
-36,242
-21% -$513K 0.01% 1135
2021
Q1
$2.52M Buy
172,462
+32,222
+23% +$547K 0.02% 856
2020
Q4
$2.44M Buy
140,240
+1,000
+0.7% +$17.8K 0.02% 788
2020
Q3
$2.55M Buy
139,240
+2,940
+2% +$54.7K 0.02% 733
2020
Q2
$2.43M Buy
+136,300
New +$2.31M 0.02% 678

Other funds holding CHRS

Public Sector Pension Investment Board (PSP Investments)'s CHRS Position: Q3 2023 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Coherus Oncology (CHRS) in Q3 2023, closing a stake of 118,708 shares — an estimated $507K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in CHRS in Q2 2020 and held it in 13 quarters. The position peaked at $2.55M in Q3 2020. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Coherus Oncology position as of Q3 2023 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 118,708 Coherus Oncology shares in Q3 2023, an estimated $507K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Coherus Oncology in Q2 2020 and held it in 13 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Coherus Oncology position peaked at $2.55M in Q3 2020.
  • 169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2023, filed 22 Nov 2023.